Vogenx Inc.
Support and Resistance Levels
Past performance
News About VOGX
All events for VOGX
All deals for VOGX
Financial Ratios
Financial Statements
VOGX vs Sector & Peers
About Vogenx Inc.
Vogenx is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of serious diseases associated with dysfunctions in human metabolism, including post-bariatric hypoglycemia (PBH) and gastroparesis. The company's lead product candidate is mizagliflozin, an orally administered, small molecule drug candidate being developed for the treatment of PBH, gastroparesis, and GIP-dependent Cushing's Syndrome. Website vogenx.com
Headquarters Raleigh, NC, US